The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
Sub-acute effects of psilocybin on EEG correlates of neural plasticity in major depression: Relationship to symptoms
Abstract
Background: Evidence suggests that serotonergic psychedelics (e.g. psilocybin), have rapid-acting and long-lasting antidepressant effects after a single dose. However, the mechanism underlying these effects remain unclear. One proposed mechanism is that these drugs promote neuroplasticity. However, this has not been conclusively demonstrated in humans. Aims: We hypothesized that relative to placebo, psilocybin would: (1) increase electroencephalographic (EEG) correlates of neuroplasticity, (2) reduce depression symptoms, and (3) changes in EEG would correlate with improvements in depression. Methods: In this double-blind, placebo-controlled, within-subject study, individuals with major depressive disorder (MDD; n = 19) were administered placebo followed by psilocybin (0.3 mg/kg) in a fixed order (placebo, followed by psilocybin 4 weeks later). EEG indices of neuroplasticity (tetanus-induced long-term potentiation) as assessed via auditory evoked theta (4–8 Hz) power and measures of depression (GRID Hamilton Rating Scale for Depression-17 (GRID-HAM-D-17)) were measured at several time-points after placebo and psilocybin (24 h and 2 weeks after each session). Results: EEG theta power doubled in amplitude 2 weeks after a single psychedelic dose of psilocybin but not after placebo. Further, improvements in depression symptoms 2 weeks after psilocybin were correlated with increases in theta power. Conclusions: The increased theta power observed represents evidence of sustained changes in the brain following psilocybin. Given the correlation with enhancement in depressive symptoms, changes in theta may represent an EEG biomarker of the sustained effects of psilocybin, and may shed light on potential mechanisms of psilocybin’s antidepressant effect. Taken together, these results complement the emerging notion that psilocybin, and perhaps other psychedelics, can produce long-term alterations in neuroplasticity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Electrophysiology studies also revealed that psilocybin reduces alpha, beta, and delta band activity in both healthy and depressed individuals”
From The revival of psilocybin between scientific excitement, evidence of efficacy, and real-world challenges (2024) · cites this paper as [28]
Citations
Cites
1 retracted
RETRACTED: Impaired Visual Cortical Plasticity in Schizophrenia
Çavuş, I., Reinhart, R. M. G., Roach, B. J., Gueorguieva, R., Teyler, T. J., Clapp, W. C., Ford, J. M., Krystal, J. H., & Mathalon, D. H. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.01.013 · Cited by 130 · cited 1×
“While traditionally studied in slice preparations, it is possible to index LTP in human subjects using sensory stimulation and electroencephalography (EEG) (Cavus et al., 2012; Clapp et al., 2012; Lei et al., 2017).”
BackgroundRetractedA synaptic model of memory: long-term potentiation in the hippocampus
Bliss, T. V. P., & Collingridge, G. L. (1993) · Nature · doi:10.1038/361031a0 · Cited by 11,566 · cited 2×
“…is typically measured using paradigms that assess long-term potentiation (LTP), which is defined as a persistent increase in synaptic strength following high-frequency stimulation, and is believed to be a neural substrate of learning and memory (Bliss and Collingridge, 1993; Lynch, 2004).”
BackgroundA new method for off-line removal of ocular artifact
Gratton, G., Coles, M. G. H., & Donchin, E. (1983) · Electroencephalography and Clinical Neurophysiology · doi:10.1016/0013-4694(83)90135-9 · Cited by 5,055 · cited 1×
“Ocular movement correction was applied using Gratton’s algorithm (Gratton et al., 1983).”
MethodGriffiths, R. R., Johnson, M. W., Carducci, M. A., Umbricht, A., Richards, W. A., Richards, B. D., Cosimano, M. P., & Klinedinst, M. A. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116675513 · Cited by 2,201 · cited 1×
“…of early phase trials have suggested that psilocybin-assisted psychotherapy may have rapid-acting and long-lasting therapeutic effects in depression, anxiety, substance use, smoking cessation, migraine, and other disorders (Carhart-Harris et al., 2016; Griffiths et al., 2016; Ross et al., 2016).”
BackgroundLong-Term Potentiation and Memory
LYNCH, M. A. (2004) · Physiological Reviews · doi:10.1152/physrev.00014.2003 · Cited by 1,991 · cited 2×
“…is typically measured using paradigms that assess long-term potentiation (LTP), which is defined as a persistent increase in synaptic strength following high-frequency stimulation, and is believed to be a neural substrate of learning and memory (Bliss and Collingridge, 1993; Lynch, 2004).”
BackgroundNeurophysiological and Computational Principles of Cortical Rhythms in Cognition
Wang, X.-J. (2010) · Physiological Reviews · doi:10.1152/physrev.00035.2008 · Cited by 1,939 · cited 1×
“Moreover, low frequencies such as theta tend to be involved in long-range communication between distal brain networks (due to constraints based upon longer conduction times (Siegel et al., 2012; Wang, 2010)).”
BackgroundRoss, S., Bossis, A., Guss, J., Agin-Liebes, G., Malone, T., Cohen, B., Mennenga, S. E., Belser, A., Kalliontzi, K., Babb, J., et al. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116675512 · Cited by 1,698 · cited 2×
“…of early phase trials have suggested that psilocybin-assisted psychotherapy may have rapid-acting and long-lasting therapeutic effects in depression, anxiety, substance use, smoking cessation, migraine, and other disorders (Carhart-Harris et al., 2016; Griffiths et al., 2016; Ross et al., 2016).”
BackgroundGriffiths, R. R., Richards, W. A., McCann, U., & Jesse, R. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0457-5 · Cited by 1,684
Carhart-Harris, R. L., Bolstridge, M., Rucker, J., Day, C. M. J., Erritzoe, D., Kaelen, M., Bloomfield, M., Rickard, J. A., Forbes, B., Feilding, A., et al. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(16)30065-7 · Cited by 1,540 · cited 1×
“…of early phase trials have suggested that psilocybin-assisted psychotherapy may have rapid-acting and long-lasting therapeutic effects in depression, anxiety, substance use, smoking cessation, migraine, and other disorders (Carhart-Harris et al., 2016; Griffiths et al., 2016; Ross et al., 2016).”
Kaplan & Sadock's Comprehensive Textbook of Psychiatry
Sadock, B. J., & Sadock, V. A. (2000) · Cited by 1,523
Research works printed but not linked: 5
- Gotvaldova K, Borovicka J, Hajkova K, et al. (2022) Extensive collection of psychotropic mushrooms with determination of their tryptamine alkaloids. Int J Mol Sci 23.
- Luscher C, Malenka RC (2012) NMDA receptor-dependent long-term potentiation and long-term depression (LTP/LTD). Cold Spring Harb Perspect Biol 4.
- Malcolm B, Thomas K (2021) Serotonin toxicity of serotonergic psychedelics. Psychopharmacology (Berl). 239: 1881–1891.
- Sumner RL, McMillan R, Spriggs MJ, et al. (2020) Ketamine enhances visual sensory evoked potential long-term potentiation in patients with major depressive disorder. Biol Psychiatry Cogn Neurosci Neuroimag 5: 45–55.
- 10.3233/RNN-2007-253407 · DOI
Cited by
Weiss, F., Magnesa, A., Gambini, M., Gurrieri, R., Annuzzi, E., Elefante, C., Perugi, G., & Marazziti, D. (2025) · Brain Sciences · doi:10.3390/brainsci15020117 · Cited by 74
“…with major depressive disorder found that psilocybin increased auditory evoked theta power two weeks after a single dose administration, and that such an increase in theta frequencies correlated with the reduction of depression scores, as measured with the clinician-administered GRID-HAMD-17 [112].”
Sloshower, J., Zeifman, R. J., Guss, J., Krause, R., Safi-Aghdam, H., Pathania, S., Pittman, B., & D’Souza, D. C. (2024) · Scientific Reports · doi:10.1038/s41598-024-58318-x · Cited by 65
“This study was designed primarily to investigate psilocy-bin’s effects on an electrophysiological biomarker of neuroplasticity (see 19 ), rather than to demonstrate changes in clinical or behavioral outcomes.”
Self-citationHolze, F., Singh, N., Liechti, M. E., & D’Souza, D. C. (2024) · Biological Psychiatry Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2024.01.007 · Cited by 78
Self-citationAgnorelli, C., Spriggs, M. J., Godfrey, K., Sawicka, G., Bohl, B., Douglass, H. M., Fagiolini, A. M., Hashemi, P., Carhart-Harris, R. L., Nutt, D. J., et al. (2025) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2025.106132 · Cited by 67
Le, G. H., Wong, S., Badulescu, S., Au, H., Di Vincenzo, J. D., Gill, H., Phan, L., Rhee, T. G., Ho, R., Teopiz, K. M., et al. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.03.165 · Cited by 30
Metadata
- Authors
- Skosnik, P. D., Sloshower, J., Safi-Aghdam, H., Pathania, S., Syed, S., Pittman, B., & D’Souza, D. C.
- Affiliations
- Yale University (US)
- Corresponding author
- Skosnik, Patrick D
- ORCID
- Venue
- Journal of Psychopharmacology
- Publisher
- SAGE Publications
- Published
- 2023-06-30
- Volume
- 37
- Issue
- 7
- Pages
- 687-697
- ISSN
- 0269-8811 (ISSN-L)
- 1461-7285
- OpenAlex
- W4382776629
- Cited by
- 51
- References
- 50
- Citations by year
- 2026: 12 · 2025: 17 · 2024: 18 · 2023: 4
- FWCI
- 14.87
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Journal of Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Neurology › Transcranial Magnetic Stimulation Studies
- Keywords
- psilocybin, major depressive disorder, neuroplasticity, EEG theta power, auditory evoked potentials, long-term potentiation, antidepressant mechanism, serotonergic psychedelics, EEG biomarkers, rapid-acting antidepressants, depressive symptoms
- MeSH terms
- Antidepressive Agents, Depression, Depressive Disorder, Major, Major Depressive Disorder, Electroencephalography, Hallucinogens, Humans, Neuronal Plasticity, Psilocybin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Sub-acute effects of psilocybin on EEG correlates of neural plasticity in major depression: Relationship to symptoms. https://app.cochat.ai/papers/10.1177/02698811231179800
- The paper
- Skosnik, P. D., Sloshower, J., Safi-Aghdam, H., Pathania, S., Syed, S., Pittman, B., & D’Souza, D. C. (2023). Sub-acute effects of psilocybin on EEG correlates of neural plasticity in major depression: Relationship to symptoms. Journal of Psychopharmacology. https://doi.org/10.1177/02698811231179800
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.